| |
|
|
| Address |
223-23,SANGDAEWON 1-DONG, JUNGWON-GU,SEONGNAM-SI,GYEONGGI-DO |
| Home Page |
www.daewoongholdings.com
|
| Established |
1961. 1.10 |
Tel |
031-741-7700 |
| Listed |
1973. 6.26 |
IR |
|
| Common shares O/S |
6,297,926 |
President |
Yun,Yeong Hwan/Jeong,Nan Yeong |
| Preferred shares O/S |
|
No.of Employees |
263(2007. 6) |
| Firm's operating profit rose, thanks to gain on valuation of investments using the equity method, deriving from good performances of affiliates including Daewoong Pharm. And RNP Korea based on 2006. Firm added TRUST as its affiliate, which focuses on consulting for ERP system design and establishment in January 2007. The upward trend of operating income and profit continues, due to favorable tune of subsidiaries' performances in Q1 of 2007. |
| As a holding company that holds Daewoong Pharm as its subsidiary, firm's gain on valuation of investments using the equity, deriving from stable performance of the subsidiary, is expected to increase. Daewoong Pharm is likely to sustain stable operating profit increase, in view of continuous profitability along with favorable tune in sales of highly profitable products. Firm's subsidiary, Daewoong Pharm, shows great R&D performances including obtaining a patent for Western type syringe material treating prostatic cancer and myoma of the uterus. |
|
  |
(date: 2007.06, unit : %) |
| Name |
Daewoong Chemical |
Yoon Yeonghwan |
Yoon Jaeseung |
| Portion |
30.9 |
16.4 |
8.1 |
|
 |
(unit : %) |
| Sales |
Cefaclor |
1.7 |
Cost |
Raw Materials |
|
| cellisys |
0.7 |
Labors |
|
| Others |
97.5 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
00. 7 |
~02. 3 |
02.11 |
~03. 3 |
03.12 |
| Type |
BI |
CB |
CR |
CB |
RI |
| Amount |
25.00 |
31.62 |
- 246.96 |
2.07 |
95.71 |
|
|
|
|
